Private area at Neuraxpharm

In this private area we strive to build a selection of resources to contribute to a dialogue among health care professionals concerning treatments for neurological and pshyquiatric disorders. If you have any suggestion to contribute to its enrichment, please contact us.




After the success of the 2020 digital congress, the DGPPN congress 2021 is being planned as an analogue-digital combination, with some of the scientific programme being livestreamed. It will offer a comprehensive overview of current developments in the field of mental health – with practical findings for prevention, diagnostics and therapy.




Neuraxpharm Spain will participate in the VII Congress of the Spanish Socienty of Epilepsy on Friday 22 of October, offering the symposium “LepsiApp: the first medical prescription app to improve epilepsy management, that will be moderated by Dr. Maria del Mar Carreño Martínez.



We offer a comprehensive portfolio of drugs mainly focused in the central nervous system and other therapeutic areas.

Training capsules


Status epilepticus (SE) is a medical emergency that carries the risk of death, permanent neurological injury or epilepsy. The purpose of the course is to highlight critical issues related to SE. Furthermore, there is a need to create a collaboration bridge between professionals to guarantee a concerted follow-up of the patient in the development phase and to create an information network continues among the various specialists.

Digestive Health

The issue related to the interaction between intestinal microbiota and the brain has reached, in recent years, great relevance within the scientific community, as evidenced by the extensive literature published over the last decade. This is the topic treated in this training capsule by Prof. Bernard Dell’Osso, director of the UOC of Psychiatry 2 at the Luigi Sacco hospital in Milan.


The quarantine period experienced by our country, as a consequence of the Covid-19 pandemic, represented a unique event that put a strain on the resilience of our health system that found itself having to make decisions that impact everyone’s life.

Scientific Materials


This review article aims to present the evidence on the association between depression and metabolic diseases, but above all to discuss the relationship between antidepressants and the metabolic risk profile. In addition, the current evidence on antidepressant pharmacotherapy in depressed patients with comorbid obesity, metabolic syndrome and T2DM is presented.


Antidepressants are among the most commonly prescribed drugs in the world. The medication is often and often discontinued without the knowledge of the practitioner. Knowledge of the withdrawal and rebound phenomena that may occur is essential for treatment, prevention and education.



Support material for family and friends diagnosed with schizophrenia. We can all play a very important role, giving the person support and helping them receive the appropriate care.


Support material on how to act during an epileptic crisis for patients and their families. “The best attention is acting.”

Digestive Health

The Spanish Society of Microbiota, Probiotics and Prebiotics (SEMiPyP), the Spanish Society of Biological Psychiatry (SEPB) and the Spanish Society of Neurology (SEN), have jointly prepared this Consensus Document in the hope that “mutualism” among scientists and clinicians generate more relevant research in this field.